A
Alyssa A. Forcehimes
Researcher at University of New Mexico
Publications - 37
Citations - 2037
Alyssa A. Forcehimes is an academic researcher from University of New Mexico. The author has contributed to research in topics: Substance abuse & Randomized controlled trial. The author has an hindex of 20, co-authored 34 publications receiving 1556 citations.
Papers
More filters
Journal ArticleDOI
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz,Alyssa A. Forcehimes,Jessica Pommy,Claire E. Wilcox,Paulo Cesar Ribeiro Barbosa,Rick J. Strassman +5 more
TL;DR: A single-group proof-of-concept study to quantify acute effects of psilocybin in alcohol-dependent participants and to provide preliminary outcome and safety data, providing a strong rationale for controlled trials with larger samples to investigate efficacy and mechanisms.
Journal ArticleDOI
Motivational interviewing : An evidence-based approach to counseling helps patients follow treatment recommendations
TL;DR: The basic theoretical underpinnings, principles, and methods of motivational interviewing are discussed, with an emphasis on acting in accordance with the "spirit" of the approach.
Journal ArticleDOI
Psychometrics of the Drinker Inventory of Consequences (DrInC)
TL;DR: In an examination of the shorter version of the DrInC, findings suggest that the SIP is suitable when assessing the overall level of drinking-related consequences and thatDrInC subscales are internally consistent and non-redundant.
Journal ArticleDOI
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.
Michael P. Bogenschutz,Dennis M. Donovan,Raul N. Mandler,Harold I. Perl,Alyssa A. Forcehimes,Cameron Crandall,Robert Lindblad,Neal Oden,Gaurav Sharma,Lisa R. Metsch,Michael S. Lyons,Ryan P. McCormack,Wendy Macias-Konstantopoulos,Antoine Douaihy +13 more
TL;DR: In this paper, the authors compared the effects of a brief intervention with telephone boosters (BI-B) with those of screening, assessment, and referral to treatment (SAR) and minimal screening only (MSO) among drug-using ED patients.
Journal ArticleDOI
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz,Stephen E. Ross,Snehal Bhatt,Tara Baron,Alyssa A. Forcehimes,Eugene M. Laska,Sarah E. Mennenga,Kelley C O’Donnell,Lindsey T. Owens,Samantha K. Podrebarac,John Rotrosen,J. Scott Tonigan,Lindsay M Worth +12 more
TL;DR: The results in this trial showed that psilocybin administered in combination with psychotherapy produced robust decreases in the percentage of heavy drinking days compared with those produced by active placebo and psychotherapy.